海外の治験の状況「前立腺癌」での検索結果
370件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Comparison of diagnostic efficiency of PSMA PET/MR, PSMA PET/CT and mpMRI in the detection of prostate cancer
- Prostate cancer
- China
- 2020-01-04
Not Recruiting
- Radium-223 Dichloride in the treatment of patients diagnosed with prostate cancer that has spread to the bone
- Castrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer patients with bone metastasis MedDRA version: 18.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
- 2012-03-28
Not recruiting
- An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
- Progressive Metastatic Prostate Cancer
- China, Hong Kong, Korea, Republic of, Taiwan
- 2014-11-13
Not recruiting
- Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer
- Asian Chemo-naïve Patients With Metastatic Castrate-resistant Prostate Cancer
- China, Korea, Republic of, Taiwan
- 2014-02-06
Not recruiting
- Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
- Prostatic Neoplasms
- Australia, Brazil, Canada, Chile, Czech Republic, Czechia, Finland, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Sweden, Taiwan, United Kingdom, United States
- 2013-12-24
Not recruiting
- Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
- Metastatic Castration-resistant Prostate Cancer;Metastatic Castration-resistant Prostate Cancer;Metastatic Castration-resistant Prostate Cancer
- Belgium, Canada, Czech Republic, Czechia, France, Italy, Netherlands, Poland, Russian Federation, Spain, United Kingdom, United States
- 2013-10-24
Not recruiting
- Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Finland, Germany, Ireland, Israel, Italy, Norway, Spain, Sweden, United Kingdom, United States
- 2013-08-30
Not Recruiting
- A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Trial Investigating Two Doses of EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer (mCRPC)
- Prostate Cancer Metastatic;C61 - Malignant neoplasm of prostate
- Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Spain, United States
- 2012-07-11
Not Recruiting
- An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Different Three-Month Degarelix Dosing Regimens in Patients With Prostate Cancer
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Belgium, Finland, France, Germany, Montenegro, Netherlands, Romania, Russian Federation, Serbia, United Kingdom
- 2012-06-21
Not recruiting
- Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
- Castration-resistant Prostate Cancer;Stage IV Prostate Cancer;Castration-resistant Prostate Cancer;Stage IV Prostate Cancer;Castration-resistant Prostate Cancer;Stage IV Prostate Cancer;Castration-resistant Prostate Cancer;Stage IV Prostate Cancer
- Singapore, United States
- 2012-02-15